A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 58,262 shares of CDNA stock, worth $928,696. This represents 0.06% of its overall portfolio holdings.

Number of Shares
58,262
Previous 32,382 79.92%
Holding current value
$928,696
Previous $632,000 34.02%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$11.57 - $20.63 $299,431 - $533,904
25,880 Added 79.92%
58,262 $847,000
Q2 2025

Aug 01, 2025

BUY
$14.18 - $20.08 $182,922 - $259,031
12,900 Added 66.21%
32,382 $632,000
Q1 2025

May 09, 2025

BUY
$17.64 - $25.07 $178,851 - $254,184
10,139 Added 108.52%
19,482 $345,000
Q4 2024

Feb 12, 2025

BUY
$20.4 - $32.2 $55,936 - $88,292
2,742 Added 41.54%
9,343 $200,000
Q3 2024

Oct 16, 2024

BUY
$14.41 - $33.99 $95,120 - $224,367
6,601 New
6,601 $206,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.